Lifeist Wellness Inc. (TSXV:LFST)
Canada · Delayed Price · Currency is CAD 0.0450
-0.0050 (-10.00%)
May 21, 2026, 3:22 PM EST
Lifeist Wellness Income Statement
Financials in millions CAD. Fiscal year is December - November.
Millions CAD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 |
| 0.26 | 0.25 | 0.59 | 1.36 | 22.07 | 21.15 | |
Revenue Growth (YoY) | -43.15% | -57.65% | -56.86% | -93.81% | 4.36% | -15.77% |
Cost of Revenue | 0.2 | 0.19 | 0.38 | 0.6 | 17.11 | 21.03 |
Gross Profit | 0.07 | 0.06 | 0.2 | 0.76 | 4.96 | 0.12 |
Selling, General & Admin | 2 | 2.38 | 4.19 | 6.01 | 18.79 | 20.27 |
Research & Development | - | - | - | - | 0.13 | 0.63 |
Operating Expenses | 2.07 | 2.46 | 4.64 | 6.95 | 20.08 | 23.88 |
Operating Income | -2.01 | -2.4 | -4.43 | -6.19 | -15.12 | -23.76 |
Interest Expense | -0.01 | -0.01 | -0.03 | -0.02 | -0 | -0.1 |
Interest & Investment Income | 0.05 | 0.05 | 0.04 | - | - | - |
Currency Exchange Gain (Loss) | -0.01 | 0 | -0.03 | -0.01 | 0.01 | -0.13 |
Other Non Operating Income (Expenses) | 0.01 | 0.01 | 0.08 | 0.07 | -1.16 | 2.4 |
EBT Excluding Unusual Items | -1.96 | -2.34 | -4.38 | -6.15 | -16.27 | -21.59 |
Merger & Restructuring Charges | - | - | - | -0.01 | -0.08 | 0.11 |
Gain (Loss) on Sale of Investments | 0.15 | -0.6 | 0.32 | 0.12 | -0.07 | -0.59 |
Asset Writedown | -0.11 | -0.11 | - | - | -2.5 | - |
Other Unusual Items | 0.06 | 0.06 | - | - | - | - |
Pretax Income | -1.86 | -2.99 | -4.05 | -6.04 | -18.92 | -22.07 |
Income Tax Expense | - | - | - | -0.03 | -0.22 | 0.16 |
Earnings From Continuing Operations | -1.86 | -2.99 | -4.05 | -6.02 | -18.7 | -22.23 |
Earnings From Discontinued Operations | - | - | 2.61 | -8.11 | 3.26 | -1.57 |
Net Income to Company | -1.86 | -2.99 | -1.45 | -14.13 | -15.44 | -23.8 |
Net Income | -1.86 | -2.99 | -1.45 | -14.13 | -15.44 | -23.8 |
Net Income to Common | -1.86 | -2.99 | -1.45 | -14.13 | -15.44 | -23.8 |
Shares Outstanding (Basic) | 38 | 38 | 32 | 24 | 21 | 20 |
Shares Outstanding (Diluted) | 38 | 38 | 32 | 24 | 21 | 20 |
Shares Change (YoY) | 10.61% | 19.20% | 30.30% | 17.17% | 6.74% | 20.41% |
EPS (Basic) | -0.05 | -0.08 | -0.05 | -0.58 | -0.74 | -1.22 |
EPS (Diluted) | -0.05 | -0.08 | -0.05 | -0.58 | -0.74 | -1.22 |
Free Cash Flow | -2.16 | -2.9 | -0.88 | -2.45 | -16.04 | -18.64 |
Free Cash Flow Per Share | -0.06 | -0.08 | -0.03 | -0.10 | -0.77 | -0.96 |
Gross Margin | 25.12% | 23.66% | 34.77% | 55.93% | 22.47% | 0.57% |
Operating Margin | -759.14% | -961.10% | -753.04% | -453.30% | -68.52% | -112.38% |
Profit Margin | -702.57% | -1198.99% | -245.51% | -1034.86% | -69.94% | -112.56% |
Free Cash Flow Margin | -815.28% | -1162.82% | -148.98% | -179.73% | -72.68% | -88.17% |
EBITDA | -2 | -2.39 | -4.41 | -6.13 | -13.93 | -22.73 |
EBITDA Margin | - | - | - | - | -63.13% | -107.48% |
D&A For EBITDA | 0.01 | 0.01 | 0.03 | 0.06 | 1.19 | 1.03 |
EBIT | -2.01 | -2.4 | -4.43 | -6.19 | -15.12 | -23.76 |
EBIT Margin | - | - | - | - | -68.52% | -112.38% |
Revenue as Reported | - | - | - | - | 22.07 | 21.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.